Latest News & Features
Americas
AbbVie has filed a declaratory judgment against Novartis, alleging that its patents covering the treatment of hepatitis C virus are invalid. 3 April 2017
Americas
A Delaware district court has invalidated four patents owned by Acorda Therapeutics after the company and Alkermes Pharma Ireland alleged that Apotex, Mylan, Roxane Laboratories and Teva infringed them. 3 April 2017
Americas
The US District Court for the District of Delaware has upheld AstraZenca’s patents protecting Zomig in a dispute with generic manufacturer Lannett. 31 March 2017
Americas
The US District Court for the District of Delaware has ordered IP licensing company Orthophoenix to pay medical device maker Medtronic’s legal fees in a patent dispute between Orthophoenix and Stryker, a medical technology company. 31 March 2017
Asia
Agriculture company Monsanto has lost a patent and trademark dispute against Indian agribusiness Nuziveedu Seeds. 30 March 2017
Americas
The US District Court for the Eastern District of Pennsylvania has dismissed a trade secret case between Pfizer and its former employee. 30 March 2017
Big Pharma
"The disadvantage of going for an Arrow declaration is that you have to put all your cards on the table," says Lorna Brazell of Osborne Clarke. 30 March 2017
Americas
Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday. 29 March 2017
Americas
The European Patent Office has revealed its intention to grant a patent covering the CRISPR gene-editing technology to the University of California, Berkeley, the University of Vienna, and inventor Emmanuelle Charpentier. 28 March 2017
Americas
The Patent Trial and Appeal Board has upheld a Research Corporation Technologies patent for anti-epileptic drug Vimpat in a case brought by Argentum Pharmaceuticals. 27 March 2017